Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Infectious Diseases and Therapy
Published in: Infectious Diseases and Therapy 8/2023

Open Access 02-08-2023 | Shingles | Review

Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review

Authors: Selim Badur, Esin Senol, Alpay Azap, Cihan Yesiloglu, Alev Ozakay, Serdar Ozturk, Adriana Guzman-Holst

Published in: Infectious Diseases and Therapy | Issue 8/2023

Login to get access

Abstract

Introduction

Herpes zoster (HZ), or shingles, is caused by the reactivation of varicella zoster virus (VZV) and typically presents as an acute, painful dermatomal rash, but can lead to long-term, distressing complications such as postherpetic neuralgia (PHN). Increasing trends in HZ cases are evident globally among the aging population; however, reviews investigating the epidemiology and clinical management of HZ in Turkey are lacking. Therefore, a literature review of local studies in Turkey was conducted to identify the data available and identify gaps in the literature.

Methods

Literature searches were carried out in PubMed and local journals to retrieve published articles that reported surveillance data, seroepidemiology, patient outcomes, or clinical management related to HZ or VZV in Turkey until April 30, 2022. Studies included primary data reports, case studies, secondary data reviews, and epidemiological studies in healthy or at-risk populations; HZ was the primary focus of the review.

Results

No studies reported VZV or HZ epidemiological data at a national level. One large retrospective study in Istanbul reported that HZ incidence rates significantly increased in adults 18–44 years of age between 2011 and 2019. Four single-center studies reported the proportion of dermatological patients with HZ at 0.43–1.56%. PHN was the most common reported complication, occurring in 8–58.9% of patients with HZ. However, out of 39 identified case reports, HZ ophthalmicus was the most frequently reported complication. Two studies highlighted poor disease awareness and risk perception of HZ among Turkish citizens.

Conclusion

Overall, there were limited comprehensive epidemiological data on HZ in Turkey. However, the abundance of case studies on HZ complications indicates a strong disease presence and diverse clinical management in Turkey. Further research will be important to understand the impact of HZ, increase disease awareness, and support the introduction of new preventative strategies.
Appendix
Available only for authorised users
Literature
1.
Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58(1):9–20.PubMedPubMedCentral
2.
3.
4.
5.
6.
7.
8.
9.
10.
United Nation, Department of Economic and Social Affairs, Population Division. World Population prospects: the 2012 revision. New York: United Nations, Department of Economic and Social Affairs, Population Division; 2013:4.
11.
12.
Turkish Statistical Institute. Elderly statistics, 2014, vol. 7. Ankara: Turkish Statistical Institute; 2015.
13.
14.
15.
16.
17.
18.
19.
Wohlin C. Guidelines for snowballing in systematic literature studies and a replication in software engineering. In: Proceedings of the 18th International Conference on Evaluation and Assessment in Software Engineering. London: Association for Computing Machinery; 2014:Article 38.
20.
21.
22.
23.
24.
25.
26.
Atiş G, Aydinİlknur E, Altunay I. Herpes zoster in geriatric patients: Clinical course and complications. Turk Geriatri Dergisi. 2017;20(3):172–7.
27.
28.
29.
Dogan S, Bildik B, Karaboga T, Kalafat UM, Yesiltas I, Ozucelik DN. Evaluation of patients diagnosed with herpes zoster in emergency departments. Res J Life Sci Bioinform Pharm Chem Sci. 2019;5(1):195–202.
30.
31.
32.
33.
34.
35.
Senol E, Azap A, Kutlu SS, et al. Demographical and clinical evaluation of herpes zoster in Turkey: a retrospective multicentre study, the VARICOMP adult study [Congress Abstract P0060]. The 28th European Congress of Clinical Microbiology and Infectious Diseases. 2018.
36.
Ku H-C, Tsai Y-T, Konara-Mudiyanselage S-P, Wu Y-L, Yu T, Ko N-Y. Incidence of herpes zoster in HIV-infected patients undergoing antiretroviral therapy: a systematic review and meta-analysis. J Clin Med. 2021;10(11):2300.CrossRefPubMedPubMedCentral
37.
38.
39.
Etgu F. Recurrent herpes zoster as a sign of HIV infection. Mid Black Sea J Health Sci. 2021;7(1):150–3.CrossRef
40.
Akalin H, Heper Y, Yilmaz E, et al. Retrospective analysis of 21 HIV/AIDS cases. Mikrobiyol Bult. 2005;39:339–43.
41.
42.
43.
44.
45.
46.
Coronavirus disease 2019 (COVID-19) Situation Report – 163. World Health Organization; 2020.
47.
48.
49.
50.
51.
52.
53.
54.
Acer E, Erdoğan HK, Bulur I, Acar EM. Evaluation of demographic and clinical characteristics of 166 patients with herpes zoster in the Kırşehir region. Turkderm Arch Dermatol Venerol. 2018;52:95–9.
55.
56.
Afşar Sİ, Uzunkulakoğlu A, Karataş M. Brachial plexopathy associated with herpes zoster infection: report of two cases and review of the literature. J PMR Sci. 2016;19:55–7.
57.
58.
59.
60.
61.
62.
Bakbak B, Çelebi ARC, Şener C. Horner’s syndrome following herpes zoster ophthalmicus. Turk Norol Derg. 2009;15:82–4.
63.
64.
Balcı K, Utku U, Özbek B. Herpes zoster ophthalmicus with sixth cranial nerve palsy: a case report. Turk J Neurol. 2008;14(5):350–2.
65.
66.
67.
68.
Çınar N, Sahin S, Okluoglu T, Batum K, Karşıdağ S. Herpes radiculopathy case presenting first with motor involvement. Eur J General Med. 2011;8(3):219–23.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
Ozel L, Toros SZ, Unal E, et al. Ramsay Hunt syndrome with atypical progress in a renal transplant recipient: a case report. Exp Clin Transplant. 2011;9(6):413–6.PubMed
84.
85.
86.
87.
88.
89.
90.
91.
92.
Yalçınbayır Ö, Gelişken Ö, Yılmaz E. Unilateral optic neuritis in a case of herpes zoster ophthalmicus. Neuroophthalmology. 2009;33(6):339–42.CrossRef
93.
94.
95.
96.
97.
98.
99.
100.
101.
Nazik S, Nazik H, Gül F, Demir B. Herpes Zoster Hastalarının Hastalıkları ile İlgili Tutum ve Beklentileri. Firat Med J. 2016;21:137–40.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
Metadata
Title
Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review
Authors
Selim Badur
Esin Senol
Alpay Azap
Cihan Yesiloglu
Alev Ozakay
Serdar Ozturk
Adriana Guzman-Holst
Publication date
02-08-2023
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 8/2023
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-023-00849-3

Other articles of this Issue 8/2023

Infectious Diseases and Therapy 8/2023 Go to the issue

Original Research

Applying Rituximab During the Conditioning Regimen Prevents Epstein–Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children’s Cohort: A Retrospective Case–Control Study

Brief Report

Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study

Correction

Correction to: An Economic Evaluation Estimating the Clinical and Economic Burden of Increased Vancomycin-Resistant Enterococcus faecium Infection Incidence in Japan

Original Research

Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain

Original Research

Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study

Original Research

Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improves the Survival of Patients with Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits